OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2

Qiong Zhu,Yesheng Fu,Chun-Ping Cui,Yi Ding,Zhikang Deng,Chao Ning,Fan Hu,Chen Qiu,Biyue Yu,Xuemei Zhou,Guan Yang,Jiang Peng,Weiguo Zou,Cui Hua Liu,Lingqiang Zhang

DOI: https://doi.org/10.1038/s41392-023-01354-2

IF: 39.3

2023-04-08

Signal Transduction and Targeted Therapy

Abstract:Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption. Dysregulation of this process leads to multiple diseases, including osteoporosis. However, the underlying molecular mechanisms are not fully understood. Here, we show that the global and conditional osteoblast knockout of a deubiquitinase Otub1 result in low bone mass and poor bone strength due to defects in osteogenic differentiation and mineralization. Mechanistically, the stability of FGFR2, a crucial regulator of osteogenesis, is maintained by OTUB1. OTUB1 attenuates the E3 ligase SMURF1-mediated FGFR2 ubiquitination by inhibiting SMURF1's E2 binding. In the absence of OTUB1, FGFR2 is ubiquitinated excessively by SMURF1, followed by lysosomal degradation. Consistently, adeno-associated virus serotype 9 (AAV9)-delivered FGFR2 in knee joints rescued the bone mass loss in osteoblast-specific Otub1 -deleted mice. Moreover, Otub1 mRNA level was significantly downregulated in bones from osteoporotic mice, and restoring OTUB1 levels through an AAV9-delivered system in ovariectomy-induced osteoporotic mice attenuated osteopenia. Taken together, our results suggest that OTUB1 positively regulates osteogenic differentiation and mineralization in bone homeostasis by controlling FGFR2 stability, which provides an optical therapeutic strategy to alleviate osteoporosis.

biochemistry & molecular biology,cell biology